Infection and Drug Resistance
Volume 14, 2021 - Issue
Open access
170
Views
7
CrossRef citations to date
0
Altmetric
Original Research
Foscarnet Therapy for Pure Red Cell Aplasia Related to Human Parvovirus B19 Infection in Kidney Transplant Recipients: A Preliminary Exploration
Yedong Yu1 Department of Kidney Disease Center, The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, People’s Republic of China
, Ruijie Bao1 Department of Kidney Disease Center, The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, People’s Republic of China
, Junhao Lyu1 Department of Kidney Disease Center, The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, People’s Republic of China;2 Department of Kidney Disease Immunology Laboratory, State Administration of Traditional Chinese Medicine of China, Hangzhou, People’s Republic of China;3 Department of Key Laboratory of Multiple Organ Transplantation, Ministry of Health of China, Hangzhou, People’s Republic of China;4 Institute of Nephropathy, Zhejiang University, Hangzhou, People’s Republic of China
, Jianyong Wu1 Department of Kidney Disease Center, The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, People’s Republic of China;2 Department of Kidney Disease Immunology Laboratory, State Administration of Traditional Chinese Medicine of China, Hangzhou, People’s Republic of China;3 Department of Key Laboratory of Multiple Organ Transplantation, Ministry of Health of China, Hangzhou, People’s Republic of China;4 Institute of Nephropathy, Zhejiang University, Hangzhou, People’s Republic of China
, Jianghua Chen1 Department of Kidney Disease Center, The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, People’s Republic of China;2 Department of Kidney Disease Immunology Laboratory, State Administration of Traditional Chinese Medicine of China, Hangzhou, People’s Republic of China;3 Department of Key Laboratory of Multiple Organ Transplantation, Ministry of Health of China, Hangzhou, People’s Republic of China;4 Institute of Nephropathy, Zhejiang University, Hangzhou, People’s Republic of China
& Wenhan Peng1 Department of Kidney Disease Center, The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, People’s Republic of China;2 Department of Kidney Disease Immunology Laboratory, State Administration of Traditional Chinese Medicine of China, Hangzhou, People’s Republic of China;3 Department of Key Laboratory of Multiple Organ Transplantation, Ministry of Health of China, Hangzhou, People’s Republic of China;4 Institute of Nephropathy, Zhejiang University, Hangzhou, People’s Republic of ChinaCorrespondence[email protected]
Pages 2911-2923
|
Published online: 27 Jul 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.